Works matching AU Vreugdenhil, G.

Results: 38

Assessing the impact of chemotherapy-induced peripheral neurotoxicity on the quality of life of cancer patients: the introduction of a new measure.

Published in:

2012

By:

Driessen CM;
de Kleine-Bolt KM;
Vingerhoets AJ;
Mols F;
Vreugdenhil G;
Driessen, C M L;
de Kleine-Bolt, K M E;
Vingerhoets, A J J M;
Mols, F;
Vreugdenhil, G

Publication type:

journal article

Adjuvant BRAF/MEK versus anti-PD-1 in BRAF-mutant melanoma: a propensity score matched survival analysis.

Published in:

British Journal of Cancer, 2025, v. 132, n. 12, p. 1124, doi. 10.1038/s41416-025-03021-5

By:

Bloem, M.;
de Meza, M. M.;
van den Eertwegh, A. J. M.;
Aarts, M. J. B.;
van den Berkmortel, F. W. P. J.;
Blank, C. U.;
Blokx, W. A. M.;
Boers-Sonderen, M. J.;
Bonenkamp, J. J.;
Boreel, C. D. M.;
de Groot, J. W. B.;
Haanen, J. B. A. G.;
Hospers, G. A. P.;
Kapiteijn, E.;
van Not, O. J.;
Piersma, D.;
Rikhof, B.;
Stevense-den Boer, A. M.;
van der Veldt, A. A. M.;
Vreugdenhil, G.

Publication type:

Article

Long-Term Survival in Patients With Advanced Melanoma.

Published in:

JAMA Network Open, 2024, v. 7, n. 8, p. e2426641, doi. 10.1001/jamanetworkopen.2024.26641

By:

van Not, Olivier J.;
van den Eertwegh, Alfons J. M.;
Jalving, Hilde;
Bloem, Manja;
Haanen, John B.;
van Rijn, Rozemarijn S.;
Aarts, Maureen J. B.;
van den Berkmortel, Franchette W. P. J.;
Blank, Christian U.;
Boers-Sonderen, Marye J.;
de Groot J. W. B., Jan Willem;
Hospers, Geke A. P.;
Kapiteijn, Ellen;
Leeneman, Brenda;
D., Piersma;
Stevense-den Boer, Marion;
van der Veldt, Astrid A. M.;
Vreugdenhil G., Gerard;
Wouters, Michel W. J. M.;
Blokx, Willeke A. M.

Publication type:

Article

Assessing the impact of chemotherapy-induced peripheral neurotoxicity on the quality of life of cancer patients.

Published in:

Supportive Care in Cancer, 2012, v. 20, n. 4, p. 877, doi. 10.1007/s00520-011-1336-0

By:

Driessen, C.;
Kleine-Bolt, K.;
Vingerhoets, A.;
Mols, F.;
Vreugdenhil, G.

Publication type:

Article

Human pancreatic duct cells can produce tumour necrosis factor-α that damages neighbouring beta cells and activates dendritic cells.

Published in:

Diabetologia, 2004, v. 47, n. 6, p. 998, doi. 10.1007/s00125-004-1426-3

By:

Movahedi, B.;
Van de Casteele, M.;
Caluwé, N.;
Stangé, G.;
Breckpot, K.;
Thielemans, K.;
Vreugdenhil, G.;
Mathieu, C.;
Pipeleers, D.

Publication type:

Article

Health-related quality of life of long-term advanced melanoma survivors treated with anti-CTLA-4 immune checkpoint inhibition compared to matched controls.

Published in:

Acta Oncologica, 2021, v. 60, n. 1, p. 69, doi. 10.1080/0284186X.2020.1818823

By:

Boekhout, A. H.;
Rogiers, A.;
Jozwiak, K.;
Boers-Sonderen, M. J.;
van den Eertwegh, A. J.;
Hospers, G. A.;
de Groot, J. W. B.;
Aarts, M. J. B.;
Kapiteijn, E.;
ten Tije, A. J.;
Piersma, D.;
Vreugdenhil, G.;
van der Veldt, A. A.;
Suijkerbuijk, K. P. M.;
Rozeman, E. A.;
Neyns, B.;
Janssen, K. J.;
van de Poll-Franse, L. V.;
Blank, C. U.

Publication type:

Article

Bevacizumab for metachronous metastatic colorectal cancer: a reflection of community based practice.

Published in:

2016

By:

Razenberg, L. G. E. M.;
van Gestel, Y. R. B. M.;
de Hingh, I. H. J. T.;
Loosveld, O. J. L.;
Vreugdenhil, G.;
Beerepoot, L. V.;
Creemers, G. J.;
Lemmens, V. E. P. P.

Publication type:

journal article

Tumor growth pattern and thymidine phosphorylase expression are related with the risk of hematogenous metastasis in patients with Astler Coller B1/B2 colorectal carcinoma.

Published in:

2001

By:

van Halteren, Henk K.;
Peters, Herman M.;
van Krieken, J. Han J. M.;
Coebergh, Jan-Willem W.;
Roumen, Rudi M. H.;
van der Worp, Erik;
Wagener, J. Theo;
Vreugdenhil, Gerard;
van Halteren, H K;
Peters, H M;
van Krieken, J H;
Coebergh, J W;
Roumen, R M;
van der Worp, E;
Wagener, J T;
Vreugdenhil, G

Publication type:

journal article

A Comparative Study of the Mouth to Caecum Transit Time in Children and Adults Using a Weight Adapted Lactulose Dose.

Published in:

Acta Paediatrica, 1986, v. 75, n. 3, p. 483, doi. 10.1111/j.1651-2227.1986.tb10234.x

By:

VREUGDENHIL, G.;
SINAASAPPEL, M.;
BOUQUET, J.

Publication type:

Article

Improvement of erythropoiesis during treatment with deferiprone in a patient with myelofibrosis and transfusional hemosiderosis.

Published in:

American Journal of Hematology, 1996, v. 51, n. 3, p. 243, doi. 10.1002/(SICI)1096-8652(199603)51:3<243::AID-AJH12>3.0.CO;2-H

By:

Smeets, M.E.P.;
Vreugdenhil, G.;
Holdrinet, R.S.G.

Publication type:

Article

Decreased affinity and number of transferrin receptors on erythroblasts in the anemia of rheumatoid arthritis.

Published in:

American Journal of Hematology, 1993, v. 43, n. 3, p. 200, doi. 10.1002/ajh.2830430308

By:

Feelders, R. A.;
Vreugdenhil, G.;
Van Dijk, J. P.;
Swaak, A. J. G.;
Van Eijk, H. G.

Publication type:

Article

Quality of life of patients with chronic lymphocytic leukaemia in the Netherlands: results of a longitudinal multicentre study.

Published in:

2015

By:

Holtzer-Goor, K.;
Schaafsma, M.;
Joosten, P.;
Posthuma, E.;
Wittebol, S.;
Huijgens, P.;
Mattijssen, E.;
Vreugdenhil, G.;
Visser, H.;
Peters, W.;
Erjavec, Z.;
Wijermans, P.;
Daenen, S.;
Hem, K.;
Oers, M.;
Uyl-de Groot, C.;
Holtzer-Goor, K M;
Schaafsma, M R;
Posthuma, E F M;
Huijgens, P C

Publication type:

journal article

ORIGINAL ARTICLE Determinants of Prognosis in Breast Cancer Patients with Tumor Involvement of the Skin (pT4b)

Published in:

2004

By:

Wieland AW;
Louwman MW;
Voogd AC;
Van Beek MW;
Vreugdenhil G;
Roumen RM

Publication type:

Journal Article

Serum transferrin receptor levels in anaemia of rheumatoid arthritis and effects of iron chelation treatment.

Published in:

European Journal of Haematology, 1994, v. 52, n. 1, p. 61, doi. 10.1111/j.1600-0609.1994.tb01286.x

By:

Feelders, R.A.;
Vreugdenhil, G.;
Manger, B.;
Eijk, H.G.;
Swaak, AJ.G.

Publication type:

Article

Interactions between erythropoietin and iron metabolism in anaemia of chronic disorders.

Published in:

European Journal of Haematology, 1992, v. 48, n. 1, p. 56, doi. 10.1111/j.1600-0609.1992.tb01794.x

By:

Vreugdenhil, G.;
Nieuwenhuizen, C.;
Swaak, A.J.G.

Publication type:

Article

Iron Chelators May Enhance Erythropoiesis by Increasing Iron Delivery to Haematopoietic Tissue and Erythropoietin Response in Iron-Loading Anaemia.

Published in:

Acta Haematologica, 1993, v. 89, n. 2, p. 57, doi. 10.1159/000204488

By:

Vreugdenhil, G.;
Smeets, M.;
Feelders, R.A.;
van Eijk, H.G.

Publication type:

Article

High-dose dexamethasone as a first- and second-line treatment of idiopathic thrombocytopenic purpura in adults.

Published in:

Annals of Hematology, 2004, v. 83, n. 12, p. 764, doi. 10.1007/s00277-004-0908-1

By:

Borst, F.;
Keuning, J.J.;
van Hulsteijn, H.;
Sinnige, H.;
Vreugdenhil, G.

Publication type:

Article

Treatment and survival of 38 female breast lymphomas: a population-based study with clinical and pathological reviews.

Published in:

Annals of Hematology, 2003, v. 82, n. 7, p. 397, doi. 10.1007/s00277-003-0664-7

By:

Kuper-Hommel, M. J. J.;
Snijder, S.;
Janssen-Heijnen, M. L. G.;
Vrints, L. W.;
Kluin-Nelemans, J. C.;
Coebergh, J. W. W.;
Noordijk, E. M.;
Vreugdenhil, G.

Publication type:

Article

Stenosis and Renographic Characteristics in Renovascular Disease.

Published in:

Journal of Nuclear Medicine, 1996, v. 37, n. 4, p. 594

By:

Schreij, G.;
Ritsema, G. H.;
Vreugdenhil, G.;
de Leeuw, P.W.

Publication type:

Article

Safe Stop IPI-NIVO trial: early discontinuation of nivolumab upon achieving a complete or partial response in patients with irresectable stage III or metastatic melanoma treated with first-line ipilimumab-nivolumab – study protocol.

Published in:

BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-12336-0

By:

Janssen, J. C.;
van Dijk, B.;
de Joode, K.;
Aarts, M. J. B.;
van den Berkmortel, F. W. P. J.;
Blank, C. U.;
Boers-Sonderen, M. J.;
van den Eertwegh, A. J. M.;
de Groot, J. W. B.;
Jalving, M.;
de Jonge, M. J. A.;
Joosse, A.;
Kapiteijn, E.;
Kamphuis-Huismans, A. M.;
Naipal, K. A. T.;
Piersma, D.;
Rikhof, B.;
Westgeest, H. M.;
Vreugdenhil, G.;
Oomen-de Hoop, E.

Publication type:

Article

IL-6-induced anaemia in rats: possible pathogenetic implications for anaemia observed in chronic inflammations.

Published in:

Clinical & Experimental Immunology, 1996, v. 103, n. 2, p. 328

By:

Jongen-Lavrencic, M.;
Peeters, H. R. M.;
Rozemuller, H.;
Rombouts, W. J. C.;
Martens, A. C. M.;
Vreugdenhil, G.;
Pillay, M.;
Cox, P. H.;
Bijser, M.;
Brutel, G.;
Breedveld, F. C.;
Swaak, A. J. G.

Publication type:

Article

Seasonal variation of anti‐PD‐1 outcome in melanoma—Results from a Dutch patient cohort.

Published in:

Pigment Cell & Melanoma Research, 2024, v. 37, n. 1, p. 15, doi. 10.1111/pcmr.13117

By:

Borgers, J. S. W.;
Burgers, F. H.;
Schina, A.;
Van Not, O. J.;
van den Eertwegh, A. J. M.;
Blank, C. U.;
Aarts, M. J. B.;
van den Berkmortel, F. W. P. J.;
de Groot, J. W. B.;
Hospers, G. A. P.;
Kapiteijn, E.;
Piersma, D.;
van Rijn, R. S.;
Boer, A. M. Stevense‐den;
van der Veldt, A. A. M.;
Vreugdenhil, G.;
Boers‐Sonderen, M. J.;
Wouters, M. W. J. M.;
Suijkerbuijk, K. P. M.;
van Thienen, J. V.

Publication type:

Article

Comorbidity has negligible impact on treatment and complications but influences survival in breast cancer patients.

Published in:

British Journal of Cancer, 2004, v. 90, n. 12, p. 2332, doi. 10.1038/sj.bjc.6601844

By:

Houterman, S;
Janssen-heijnen, Mlg;
Verheij, Cdgw;
Louwman, Wj;
Vreugdenhil, G;
Sangen, Mjc Van Der;
Coebergh, Jww

Publication type:

Article

Early discontinuation of PD-1 blockade upon achieving a complete or partial response in patients with advanced melanoma: the multicentre prospective Safe Stop trial.

Published in:

2021

By:

Mulder, E. E. A. P.;
de Joode, K.;
Litière, S.;
ten Tije, A. J.;
Suijkerbuijk, K. P. M.;
Boers-Sonderen, M. J.;
Hospers, G. A. P.;
de Groot, J. W. B.;
van den Eertwegh, A. J. M.;
Aarts, M. J. B.;
Piersma, D.;
van Rijn, R. S.;
Kapiteijn, E.;
Vreugdenhil, G.;
van den Berkmortel, F. W. P. J.;
Hoop, E. Oomen-de;
Franken, M. G.;
Ryll, B.;
Rutkowski, P.;
Sleijfer, S.

Publication type:

journal article

Health-state utilities in long-term advanced melanoma survivors comparable with the general population.

Published in:

Quality of Life Research, 2023, v. 32, n. 9, p. 2517, doi. 10.1007/s11136-023-03427-9

By:

Egeler, M. D.;
van de Poll-Franse, L. V.;
Tissier, R.;
Rogiers, A.;
Boers-Sonderen, M. J.;
van den Eertwegh, A. J.;
Hospers, G. A.;
de Groot, J. W. B.;
Aarts, M. J. B.;
Kapiteijn, E.;
Piersma, D.;
Vreugdenhil, G.;
van der Veldt, A. A.;
Suijkerbuijk, K. P. M.;
Neyns, B.;
Janssen, K. J.;
Blank, C. U.;
Retèl, V. P.;
Boekhout, A. H.

Publication type:

Article

Inhibition of Emotional Expression in Breast Cancer Patients.

Published in:

Behavioral Medicine, 1999, v. 25, n. 1, p. 23, doi. 10.1080/08964289909596735

By:

Servaes, P.;
Vingerhoets, A.J.J.M.;
Vreugdenhil, G.;
Keuning, J.J.;
Broekhuijsen, A.M.

Publication type:

Article

Changes in perception of prognosis in the last year of life of patients with advanced cancer and its associated factors: Longitudinal results of the eQuiPe study.

Published in:

Palliative Medicine, 2025, v. 39, n. 2, p. 277, doi. 10.1177/02692163241301220

By:

Versluis, M.A.J.;
van de Poll-Franse, L.V.;
Zijlstra, M.;
van Laarhoven, H.W.M.;
Vreugdenhil, G.;
Henselmans, I.;
Brom, L.;
Kuip, E.J.M;
van der Linden, Y.M.;
Raijmakers, N.H.J.

Publication type:

Article

LETTERS TO THE EDITOR.

Published in:

British Journal of Rheumatology, 1992, v. 31, n. 3, p. 212

By:

VREUGDENHIL, G.;
SWAAK, A. J. G.

Publication type:

Article

Perception of prognosis and health-related quality of life in patients with advanced cancer: results of a multicentre observational study (eQuiPe)

Published in:

Supportive Care in Cancer, 2023, v. 31, n. 3, p. 1, doi. 10.1007/s00520-023-07631-8

By:

Zijlstra, Myrte;
van Roij, J.;
Henselmans, I.;
van Laarhoven, H. W. M.;
Creemers, G. J.;
Vreugdenhil, G.;
Kuip, E. J. M.;
van de Poll-Franse, L. V.;
Raijmakers, N. J. H.

Publication type:

Article

Painful and non-painful chemotherapy-induced peripheral neuropathy and quality of life in colorectal cancer survivors: results from the population-based PROFILES registry.

Published in:

Supportive Care in Cancer, 2020, v. 28, n. 12, p. 5933, doi. 10.1007/s00520-020-05438-5

By:

Bonhof, C. S.;
Trompetter, H. R.;
Vreugdenhil, G.;
van de Poll-Franse, L. V.;
Mols, F.

Publication type:

Article

Chemotherapy-induced neuropathy in multiple myeloma: influence on quality of life and development of a questionnaire to compose common toxicity criteria grading for use in daily clinical practice.

Published in:

2016

By:

Beijers, A.;
Vreugdenhil, G.;
Oerlemans, S.;
Eurelings, M.;
Minnema, M.;
Eeltink, C.;
Poll-Franse, L.;
Mols, F.;
Beijers, A J M;
Minnema, M C;
Eeltink, C M;
van de Poll-Franse, L V

Publication type:

journal article

A systematic review on chronic oxaliplatin-induced peripheral neuropathy and the relation with oxaliplatin administration.

Published in:

Supportive Care in Cancer, 2014, v. 22, n. 7, p. 1999, doi. 10.1007/s00520-014-2242-z

By:

Beijers, A.;
Mols, F.;
Vreugdenhil, G.

Publication type:

Article

Tumor necrosis factor alpha is associated with disease activity and the degree of anemia in patients with rheumatoid arthritis.

Published in:

European Journal of Clinical Investigation, 1992, v. 22, n. 7, p. 488, doi. 10.1111/j.1365-2362.1992.tb01495.x

By:

VREUGDENHIL, G.;
LÖWENBERG, B.;
EIJK, H. G. VAN;
SWAAK, A. J. G.

Publication type:

Article

Iron-chelating agents in non-iron overload conditions.

Published in:

1994

By:

Voest, E.E.;
Vreugdenhil, G.;
Marx, J.J.M;
Marx, J J

Publication type:

journal article

Survival of sentinel node biopsy versus observation in intermediate-thickness melanoma: A Dutch population-based study.

Published in:

PLoS ONE, 2021, v. 16, n. 5, p. 1, doi. 10.1371/journal.pone.0252021

By:

Roumen, R. M. H.;
Schuurman, M. S.;
Aarts, M. J.;
Maaskant-Braat, A. J. G.;
Vreugdenhil, G.;
Louwman, W. J.

Publication type:

Article

Survival of stage IV melanoma in Belgium and the Netherlands.

Published in:

Journal of the European Academy of Dermatology & Venereology, 2022, v. 36, n. 2, p. e118, doi. 10.1111/jdv.17668

By:

Suijkerbuijk, K.P.M.;
Haanen, J.B.A.G.;
Boers‐Sonderen, M.J.;
Hospers, G.A.P.;
Blank, C.U.;
van den Berkmortel, F.W.P.J.;
de Groot, J.W.B.;
Piersma, D.;
Aarts, M.J.B.;
van Rijn, R.S.;
Vreugdenhil, G.;
Westgeest, H.M.;
Kapiteijn, E.;
van der Veldt, A.A.M.;
van den Eertwegh, A.J.M.

Publication type:

Article

Comment on: 'Subgroup effects in a randomized trial of different types and doses of exercise during breast cancer chemotherapy'.

Published in:

British Journal of Cancer, 2015, v. 112, n. 11, p. 1835, doi. 10.1038/bjc.2014.614

By:

Beijers, A J M;
Verhulst, A L J;
Mols, F;
Vreugdenhil, G

Publication type:

Article

Long-term follow-up after cancer rehabilitation using high-intensity resistance training: persistent improvement of physical performance and quality of life.

Published in:

2008

By:

De Backer, I. C.;
Vreugdenhil, G.;
Nijziel, M. R.;
Kester, A. D.;
van Breda, E.;
Schep, G.

Publication type:

journal article